Home » Topics » Conferences

Conferences
RSS

Novel ACAT inhibitors from DuPont Pharmaceuticals debut at ACS meeting

Sep. 9, 1998

DuPont presents XJ-304 and related compounds as ACAT inhibitors at ACS

Sep. 9, 1998

WHI investigators design novel inhibitors of EGF receptor tyrosine kinase

Sep. 9, 1998

Taisho and Nihon Nohyaku describe development of potential new antipsychotics at ACS meeting

Sep. 9, 1998

Lepirudin more effective than heparin in preventing cardiac events in unstable angina

Sep. 9, 1998

Pfizer selects GH secretagogue as development candidate

Sep. 8, 1998

Lilly's mGlu agonists exert neuroprotective effects in vivo

Sep. 8, 1998

Novel lipid-lowering agent presented by Wayne Hughes Institute at scientific forum

Sep. 8, 1998

Novel actions of statins reported at the 20th Congress of the European Society of Cardiology

Sep. 8, 1998

Efficacy and safety of sublingual apomorphine in treatment of MED

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.